Please login to the form below

Not currently logged in
Email:
Password:

Envigo

This page shows the latest Envigo news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    Lynn Lewis joins Envigo. She becomes the CRO’s senior vice president of global sales. ... Dr Adrian Hardy, president and chief executive officer of Envigo, said: “We are thrilled Lynn Lewis has joined our team to drive this important effort.

  • Envigo appoints Lizanne Muller as president, EMEA operations Envigo appoints Lizanne Muller as president, EMEA operations

    Envigo appoints Lizanne Muller as president, EMEA operations. And Craig Boyd joins from Mayne Pharma as chief commercial officer. ... Contract research organisation Envigo has appointed Lizanne Muller as president of its EMEA operations.

  • Envigo appoints Dr Adrian Hardy as president and CEO Envigo appoints Dr Adrian Hardy as president and CEO

    Envigo appoints Dr Adrian Hardy as president and CEO. He succeeds Brian Cass in the role. ... firm. Prior to joining Envigo, Dr Hardy was a product development manager for Novartis, and served as a director at law firm iPulse.

  • Envigo appoints Patricia Henahan as chief financial officer Envigo appoints Patricia Henahan as chief financial officer

    Envigo appoints Patricia Henahan as chief financial officer. She brings experience from AZ, Eli Lilly and Hospira. ... Research company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer.

More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics